William Sharfman Selected Research

William Sharfman Research Topics

12	Melanoma (Melanoma, Malignant) 01/2021 - 06/2005
9	Neoplasms (Cancer) 01/2021 - 03/2010
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 01/2017
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Colitis 01/2021
1	Infections 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Sinusitis 10/2017
1	Encephalitis (Encephalitis, Rasmussen) 01/2017
1	Headache (Headaches) 01/2017
1	Disease Progression 06/2005

8	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2017
5	IpilimumabIBA 01/2021 - 10/2013
5	NivolumabIBA 01/2021 - 01/2017
2	InterferonsIBA 01/2021 - 10/2020
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 01/2018
1	CarcinogensIBA 01/2021
1	tofacitinibIBA 01/2021
1	dabrafenibIBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	trametinibIBA 01/2018
1	Lactate Dehydrogenase 5IBA 01/2018
1	RAF265IBA 08/2017
1	raf KinasesIBA 08/2017
1	Biomarkers (Surrogate Marker)IBA 08/2017
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017
1	AntibodiesIBA 01/2017
1	Interleukin-2 (IL2)IBA 10/2013
1	Immunoglobulin G (IgG)IBA 03/2010
1	etaracizumabIBA 03/2010
1	Monoclonal AntibodiesIBA 03/2010
1	Integrin alphaVbeta3IBA 03/2010
1	Integrin beta3 (GPIIIa)IBA 03/2010
1	Dacarbazine (DIC)FDA LinkGeneric 03/2010
1	Bortezomib (Velcade)FDA Link 06/2005
1	Proteasome InhibitorsIBA 06/2005